Press Releases

UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.

Elligo Health Research Expands EU and U.K. Clinical Trial Support With WHYZE Health

Elligo Health Research announces a new collaboration with Ireland-based WHYZE Health.

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics

Intego Clinical Scientists Accepted to Present on Generative AI and Statistical Programming Challenges in the Pharmaceutical Industry at PHUSE US Connect 2024

Intego Clinical has been accepted to provide three presentations and papers at this year’s PHUSE US Connect – the clinical data science conference.

Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Rare Disease Day: Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

AES Clean Technology appoints new Vice President of Engineering

Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.

Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications

Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.

Horizon CME Announces First Annual Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).

ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer

ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.

Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology

Paradigm Clinical Research Expands Into Boise, Idaho, Advancing the Company’s Portfolio of Therapeutic Area Expertise

CD BioSciences Announces Its Self-Developed Alginate Products, Looking to Fulfill Research Needs

CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.

Alfa Chemistry Unveils Expanded Assortment of Derivatization Reagents for Use in Gas Chromatography (GC)

Amerigo Scientific Launches DOPC Nanodiscs as An Invaluable Tool for Handling Membrane Proteins

Clinical Trial Media Tops Over 1,000 Participants Enrolled in Alzheimer’s Disease Studies Across 400 Trial Sites

Clinical Trial Media is Responsible for Identifying, Recruiting and Contributing Over 45% of Participants Across Multiple High-Demand Trials